These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 33781277)

  • 21. A triple-stimulus responsive melanin-based nanoplatform with an aggregation-induced emission-active photosensitiser for imaging-guided targeted synergistic phototherapy/hypoxia-activated chemotherapy.
    Yu J; Zhang X; Pei Z; Shuai Q
    J Mater Chem B; 2021 Nov; 9(44):9142-9152. PubMed ID: 34693960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An efficient delivery of photosensitizers and hypoxic prodrugs for a tumor combination therapy by membrane camouflage nanoparticles.
    Wang H; Zhang C; Zhang Y; Tian R; Cheng G; Pan H; Cui M; Chang J
    J Mater Chem B; 2020 Apr; 8(14):2876-2886. PubMed ID: 32191252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Light-Decomposable Polymeric Micelles with Hypoxia-Enhanced Phototherapeutic Efficacy for Combating Metastatic Breast Cancer.
    Li Y; Tong A; Niu P; Guo W; Jin Y; Hu Y; Tao P; Miao W
    Pharmaceutics; 2022 Jan; 14(2):. PubMed ID: 35213986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of the bioreductive drug tirapazamine with the chemotherapeutic prodrug cyclophosphamide for P450/P450-reductase-based cancer gene therapy.
    Jounaidi Y; Waxman DJ
    Cancer Res; 2000 Jul; 60(14):3761-9. PubMed ID: 10919648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimized Combination of Photodynamic Therapy and Chemotherapy Using Gelatin Nanoparticles Containing Tirapazamine and Pheophorbide a.
    Lee D; Jang SY; Kwon S; Lee Y; Park E; Koo H
    ACS Appl Mater Interfaces; 2021 Mar; 13(9):10812-10821. PubMed ID: 33624503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engineered biomimetic nanoreactor for synergistic photodynamic-chemotherapy against hypoxic tumor.
    Guo H; Wang L; Wu W; Guo M; Yang L; Zhang Z; Cao L; Pu F; Huang X; Shao Z
    J Control Release; 2022 Nov; 351():151-163. PubMed ID: 36122895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ABCG2 transporter inhibitor restores the sensitivity of triple negative breast cancer cells to aminolevulinic acid-mediated photodynamic therapy.
    Palasuberniam P; Yang X; Kraus D; Jones P; Myers KA; Chen B
    Sci Rep; 2015 Aug; 5():13298. PubMed ID: 26282350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbon monoxide (CO)-Strengthened cooperative bioreductive anti-tumor therapy via mitochondrial exhaustion and hypoxia induction.
    Li Y; Dang J; Liang Q; Yin L
    Biomaterials; 2019 Jul; 209():138-151. PubMed ID: 31034982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyaluronan-fullerene/AIEgen nanogel as CD44-targeted delivery of tirapazamine for synergistic photodynamic-hypoxia activated therapy.
    Hong X; Xu X; Liu Z; Liu S; Yu J; Wu M; Ma Y; Shuai Q
    Nanotechnology; 2021 Aug; 32(46):. PubMed ID: 34325415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silk fibroin-capped metal-organic framework for tumor-specific redox dyshomeostasis treatment synergized by deoxygenation-driven chemotherapy.
    Yu H; Li Y; Zhang Z; Ren J; Zhang L; Xu Z; Kang Y; Xue P
    Acta Biomater; 2022 Jan; 138():545-560. PubMed ID: 34775125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tirapazamine combined with photodynamic therapy improves the efficacy of ABZSO nanoparticles on Echinococcosis granulosus via further enhancing "breaking-then-curing".
    Gong Y; Zhou T; Aimaiti W; Lin Y; Xu Y; Yang J; Huang Z; Wen H; Jiang H; Wang J
    J Photochem Photobiol B; 2023 Nov; 248():112798. PubMed ID: 37820499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A photothermal-hypoxia sequentially activatable phase-change nanoagent for mitochondria-targeting tumor synergistic therapy.
    Qu J; Teng D; Sui G; Guan S; Wang Y; Wang Q; Lin Y; Ran H; Wang Z; Wang H
    Biomater Sci; 2020 Jun; 8(11):3116-3129. PubMed ID: 32352102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PEGylated hydrazided gold nanorods for pH-triggered chemo/photodynamic/photothermal triple therapy of breast cancer.
    Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
    Acta Biomater; 2018 Dec; 82():171-183. PubMed ID: 30336271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subcellular Location of Tirapazamine Reduction Dramatically Affects Aerobic but Not Anoxic Cytotoxicity.
    Guise CP; Abbattista MR; Anderson RF; Li D; Taghipouran R; Tsai A; Lee SJ; Smaill JB; Denny WA; Hay MP; Wilson WR; Hicks KO; Patterson AV
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33105798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer cell membrane-coated biomimetic platform for tumor targeted photodynamic therapy and hypoxia-amplified bioreductive therapy.
    Li SY; Cheng H; Qiu WX; Zhang L; Wan SS; Zeng JY; Zhang XZ
    Biomaterials; 2017 Oct; 142():149-161. PubMed ID: 28735175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved effectiveness of X-PDT against human triple-negative breast cancer cells through the use of liposomes co-loaded with protoporphyrin IX and perfluorooctyl bromide.
    Yang B; Sang R; Li Y; Goldys EM; Deng W
    J Mater Chem B; 2024 Apr; 12(15):3764-3773. PubMed ID: 38533806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesoporous silica-based versatile theranostic nanoplatform constructed by layer-by-layer assembly for excellent photodynamic/chemo therapy.
    Chen WH; Luo GF; Qiu WX; Lei Q; Liu LH; Wang SB; Zhang XZ
    Biomaterials; 2017 Feb; 117():54-65. PubMed ID: 27936417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and effects of functionalized liposomes targeting breast cancer tumors using chemotherapy, phototherapy, and immunotherapy.
    Zeng B; Pian L; Liu Y; Wang S; Wang N; Liu C; Wu H; Wan H; Chen L; Huang W; Gao Z; Yin X; Jin M
    J Nanobiotechnology; 2024 Sep; 22(1):558. PubMed ID: 39267061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enzyme/GSH dual-responsive biodegradable nanohybrid for spatiotemporally specific photodynamic and hypoxia-augmented therapy against tumors.
    Cheng D; Ji Y; Wang B; Jin T; Xu Y; Qian X; Zhu W
    Int J Pharm; 2021 Jun; 603():120730. PubMed ID: 34029662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies related to the enhanced the effect of 5-aminolevulinic acid-based photodynamic therapy combined with tirapazamine.
    Wang Q; Suo Y; Shi R; Wang Y
    Photodiagnosis Photodyn Ther; 2024 Oct; 49():104287. PubMed ID: 39059759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.